Derek Toth

Derek Toth is a seasoned professional in bioanalytical development and validation, currently serving as Sr. Director at Emergent BioSolutions since February 2014, where responsibilities include overseeing the development and validation of analytical and bioanalytical assays for various regulatory compliance. Previous roles include Director of BioAnalytical and Quality Sciences at Cangene Corporation and Amgen, with a focus on in-vitro bioassay development and validation for immunogenicity and biologically active drug levels in clinical settings. Derek's extensive experience encompasses management oversight of GLP/GCP studies and expertise in various analytical technologies, alongside foundational roles in assay development. Academically, Derek holds an MBA in Finance and a BSc (Hons) in Biotechnology from the University of Manitoba.